Status | Study |
Completed |
Study Name: Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis Condition: To Determine the Prevalence of Latent Tuberculosis in Each Group Date: 2012-09-11 |
Terminated |
Study Name: Determining Risk in Latent Tuberculosis Condition: Latent Tuberculosis Date: 2012-04-04 |
Active, not recruiting |
Study Name: TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment Condition: Latent Tuberculosis Infection Date: 2012-03-06 Interventions: Other: Cell phone text messages Participants in the intervention arm will receive weekly text messages f |
Completed |
Study Name: Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT Condition: Latent Tuberculosis Infection Date: 2012-02-10 Interventions: Behavioral: Self Administered Therapy (SAT) |
Completed |
Study Name: Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients Condition: Latent Tuberculosis Infection Date: 2011-07-05 |
Recruiting |
Study Name: Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI) Condition: Latent Tuberculosis Infection Date: 2011-07-01 Interventions: Drug: 4-month rifampin vs. 9-month isoniazid In the 4M-RMP group, enrolled subjects received 600 mg rifa |
Completed |
Study Name: Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection Condition: Tuberculosis Latent Tuberculosis Date: 2010-07-12 |
Completed |
Study Name: Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection Condition: Latent Tuberculosis Infection Tuberculosis Date: 2010-05-31 Interventions: Biological: RUTI dose:5 microg |
Completed |
Study Name: Improving Latent Tuberculosis (TB) Diagnosis in Thai Children Condition: Latent Tuberculosis HIV Infections Date: 2009-07-27 |
Active, not recruiting |
Study Name: Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness Condition: Latent Tuberculosis Infection Date: 2009-07-01 Interventions: Drug: Isoniazid The dosage of |